HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $399,648 | +5.9% | 10,462 | 0.0% | 0.03% | +8.0% |
| Q2 2023 | $377,364 | -5.6% | 10,462 | 0.0% | 0.02% | -13.8% |
| Q1 2023 | $399,544 | -32.9% | 10,462 | 0.0% | 0.03% | -37.0% |
| Q4 2022 | $595,288 | +43.8% | 10,462 | 0.0% | 0.05% | +27.8% |
| Q3 2022 | $414,000 | -10.0% | 10,462 | 0.0% | 0.04% | -7.7% |
| Q2 2022 | $460,000 | +2.4% | 10,462 | -2.7% | 0.04% | +18.2% |
| Q1 2022 | $449,000 | +3.9% | 10,750 | 0.0% | 0.03% | +10.0% |
| Q4 2021 | $432,000 | -1.1% | 10,750 | 0.0% | 0.03% | -9.1% |
| Q3 2021 | $437,000 | -10.5% | 10,750 | 0.0% | 0.03% | -13.2% |
| Q2 2021 | $488,000 | +8.9% | 10,750 | 0.0% | 0.04% | -2.6% |
| Q1 2021 | $448,000 | +16.7% | 10,750 | +19.4% | 0.04% | +2.6% |
| Q4 2020 | $384,000 | +1436.0% | 9,000 | +254.6% | 0.04% | +660.0% |
| Q4 2016 | $25,000 | -19.4% | 2,538 | 0.0% | 0.01% | -16.7% |
| Q3 2016 | $31,000 | +40.9% | 2,538 | 0.0% | 0.01% | +20.0% |
| Q2 2016 | $22,000 | -8.3% | 2,538 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $24,000 | -11.1% | 2,538 | +65.0% | 0.01% | -28.6% |
| Q4 2015 | $27,000 | +28.6% | 1,538 | 0.0% | 0.01% | +16.7% |
| Q3 2015 | $21,000 | -40.0% | 1,538 | 0.0% | 0.01% | -33.3% |
| Q2 2015 | $35,000 | +59.1% | 1,538 | 0.0% | 0.01% | +50.0% |
| Q1 2015 | $22,000 | – | 1,538 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |